Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06253065
What this trial is testing

Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer

Who this might be right for
Prostatic NeoplasmsLymphatic Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 225
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Not applicableStudy completedNCT01943500
What this trial is testing

Collection of Blood Specimens for Circulating Tumor Cell Analysis

Who this might be right for
Breast CancerProstate CancerColorectal Cancer
Viatar LLC 14
Early research (Phase 1)Study completedNCT00667537
What this trial is testing

PK in Pts With HRPC & Skeletal Metastes

Who this might be right for
Prostatic Neoplasms
Bayer 6
Testing effectiveness (Phase 2)WithdrawnNCT02793219
What this trial is testing

Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center, Houston
Early research (Phase 1)Study completedNCT04087174
What this trial is testing

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 27
Post-approval studies (Phase 4)UnknownNCT04882618
What this trial is testing

Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.

Who this might be right for
Prostate CancerLymph Node Metastases
TC Erciyes University 50
Not applicableWithdrawnNCT02742259
What this trial is testing

Validation of the Prostate Cancer Assay - Beta+Pivotal

Who this might be right for
Metastatic Prostate Cancer, CTC
Celsee Diagnostics
Early research (Phase 1)Looking for participantsNCT07103018
What this trial is testing

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer PatientsMetastatic Castration-resistant Prostate Cancer, mCRPC+2 more
K36 Therapeutics, Inc. 144
Early research (Phase 1)Study completedNCT01219790
What this trial is testing

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
Institut Cancerologie de l'Ouest 30
Not applicableLooking for participantsNCT07690579
What this trial is testing

Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Metastases
University of California, San Francisco 350
Early research (Phase 1)Looking for participantsNCT06545942
What this trial is testing

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more
MOMA Therapeutics 220
Testing effectiveness (Phase 2)Study completedNCT00061126
What this trial is testing

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Who this might be right for
Prostate Cancer
Abgenix 50
Not applicableStudy completedNCT06179706
What this trial is testing

11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients.

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 20
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Testing effectiveness (Phase 2)Study completedNCT01929655
What this trial is testing

Japanese BAY88-8223 Monotherapy Phase II Study

Who this might be right for
Prostatic Neoplasms
Bayer 49
Large-scale testing (Phase 3)Ended earlyNCT04261777
What this trial is testing

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastasisProstatectomy
Saving Patients' Lives Medical B.V. 172
Testing effectiveness (Phase 2)Study completedNCT02463799
What this trial is testing

Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Next Page